VOR BIOPHARMA INC's ticker is VOR and the CUSIP is 929033108. A total of 59 filers reported holding VOR BIOPHARMA INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,689 | -31.3% | 3,627 | 0.0% | 0.00% | – |
| Q2 2023 | $11,189 | +24.3% | 3,627 | +133.5% | 0.00% | – |
| Q1 2022 | $9,000 | -50.0% | 1,553 | 0.0% | 0.00% | – |
| Q4 2021 | $18,000 | -25.0% | 1,553 | 0.0% | 0.00% | – |
| Q3 2021 | $24,000 | +33.3% | 1,553 | +59.9% | 0.00% | – |
| Q2 2021 | $18,000 | -64.7% | 971 | -17.4% | 0.00% | – |
| Q1 2021 | $51,000 | – | 1,176 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 5AM Venture Management, LLC | 6,361,723 | $38,425,000 | 8.39% |
| OUP Management Co., LLC | 374,714 | $2,263,000 | 1.72% |
| RA Capital Management | 11,120,973 | $67,171,000 | 1.47% |
| Paradigm Biocapital Advisors LP | 894,404 | $5,402,000 | 1.43% |
| JOHNSON & JOHNSON | 1,074,658 | $6,491,000 | 1.23% |
| Sarissa Capital Management LP | 707,010 | $4,270,000 | 0.40% |
| Artal Group S.A. | 550,000 | $3,322,000 | 0.14% |
| Woodline Partners LP | 1,111,123 | $6,711,000 | 0.11% |
| Orbimed Advisors | 833,333 | $5,033,000 | 0.08% |
| Laurion Capital Management LP | 857,308 | $5,178,000 | 0.06% |